Stocks and Investing
Stocks and Investing
Wed, January 6, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, January 5, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Yi Chen Maintained (XRAY) at Hold with Increased Target to $55 on, Jan 5th, 2021
Published on 2024-10-27 15:06:43 - WOPRAI, Yi Chen
Yi Chen of HC Wainwright & Co., Maintained "DENTSPLY SIRONA Inc." (XRAY) at Hold with Increased Target from $49 to $55 on, Jan 5th, 2021.
Yi has made no other calls on XRAY in the last 4 months.
There are 2 other peers that have a rating on XRAY. Out of the 2 peers that are also analyzing XRAY, 1 agrees with Yi's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jonathan Block of "Stifel" Downgraded from Strong Buy to Hold and Held Target at $52 on, Friday, December 18th, 2020
This is the rating of the analyst that currently disagrees with Yi
- Steven Valiquette of "Barclays" Downgraded from Hold to Sell and Held Target at $40 on, Tuesday, November 17th, 2020
Contributing Sources